Guggenheim Maintains Buy on ProMIS Neurosciences, Lowers Price Target to $35

ProMIS Neurosciences Inc. -3.74%

ProMIS Neurosciences Inc.

PMN

11.84

-3.74%

Guggenheim analyst Eddie Hickman maintains ProMIS Neurosciences (NASDAQ: PMN) with a Buy and lowers the price target from $125 to $35.